View Older Stories View More Recent Stories

May 8, 2020 09:00AM Research from University of Washington Demonstrates High Performance of Abbott's SARS-CoV-2 Antibody Blood Test
May 5, 2020 08:00AM Absolute Empowers Customers to Extend Power of Self-Healing to More Mission-Critical Security Applications
Apr 30, 2020 08:00AM New Absolute Insights Reveal Increases in Enterprise and Education Device Usage, Vulnerability of Sensitive Data as Endpoints Remain Fragile Amid COVID-19 Outbreak
Apr 27, 2020 11:52AM Absolute to Host Conference Call for Fiscal 2020 Third Quarter Financial Results
Apr 20, 2020 03:35PM Absolute Declares Quarterly Dividend
Apr 16, 2020 07:30AM Abbott Reports First-Quarter 2020 Results
Apr 15, 2020 09:06AM Abbott (ABT) Launches Third COVID-19 Test, Laboratory-Based Antibody Blood Test
Apr 15, 2020 09:05AM Abbott Launches Third COVID-19 Test, a Laboratory-Based Antibody Blood Test That Will Ship in the U.S. Starting Tomorrow
Apr 14, 2020 05:10PM Abbott Announces Virtual Attendance at Annual Meeting of Shareholders
Apr 9, 2020 09:04AM Abbott (ABT) Announces TriClip Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Apr 9, 2020 09:00AM Abbott's TriClip™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
Apr 8, 2020 10:09AM Abbott (ABT) Announces FreeStyle Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes
Apr 8, 2020 10:07AM Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic
Apr 7, 2020 11:09AM Dorset & Wiltshire Fire and Rescue Service Rely on Absolute to Ensure Endpoint Resilience and Privacy of Sensitive Information
Mar 30, 2020 06:10AM Abbott (ABT) Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
Mar 27, 2020 07:20PM Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
Mar 19, 2020 09:00AM Abbott Hosts Conference Call for First-Quarter Earnings
Mar 18, 2020 06:04PM Abbott (ABT) Receives FDA Emergency Use Authorization for COVID-19 Test
Mar 18, 2020 06:00PM Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
Mar 5, 2020 09:00AM Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery System for the Company's Portico™ Valve
Feb 21, 2020 10:57AM Abbott Declares 385th Consecutive Quarterly Dividend
Feb 20, 2020 08:00AM New Real-World Data Show that Abbott's FreeStyle Libre System Delivers Positive Health Outcomes for People with Type 1 and Type 2 Diabetes
Feb 19, 2020 06:30AM Abbott and Insulet Partner to Integrate Next-Generation Glucose Sensing and Automated Insulin Delivery Technologies for Seamless Diabetes Care
Feb 18, 2020 07:45AM Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Feb 4, 2020 09:02AM Abbott (ABT) Granted FDA Breakthrough Device Designation for In-Development Fully Implantable Heart Pump System
Feb 4, 2020 09:00AM Abbott's In-Development Fully Implantable Heart Pump System Earns FDA's Breakthrough Device Designation
Feb 3, 2020 04:00PM Absolute Reports Fiscal 2020 Second Quarter Financial Results
Feb 3, 2020 09:03AM Abbott (ABT) Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke
Feb 3, 2020 09:00AM Abbott Announces First-of-Its-Kind Trial to Assess New Therapy Option for People at Risk of Stroke
Jan 30, 2020 09:05AM Abbott (ABT) Tendyne Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Jan 30, 2020 09:00AM Abbott's Tendyne™ Device Receives World's First CE Mark for Transcatheter Mitral Valve Implantation
Jan 24, 2020 09:01AM Abbott (ABT) Receives Expanded Indication From FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Jan 24, 2020 09:00AM Abbott Receives Expanded Indication From the U.S. FDA for Directional Deep Brain Stimulation System to Treat Parkinson's Disease
Jan 23, 2020 09:00AM New Quality of Life and Functional Improvement Data From Abbott's BOLD and TRIUMPH Studies Reinforce Benefit of Proclaim™ XR Neurostimulation System In People Living with Chronic Pain
Jan 22, 2020 07:30AM Abbott Reports Fourth-Quarter 2019 Results; Announces Strong Forecast for 2020
Jan 20, 2020 06:06PM Absolute Declares Quarterly Dividend
Jan 16, 2020 08:00AM Absolute Protects Patient Data and Supports HIPAA Compliance for Apria Healthcare
Jan 13, 2020 09:00AM Abbott to Initiate Trial to Study MitraClip as an Option for Moderate Surgical Risk Patients
Jan 7, 2020 10:05AM Abbott (ABT) Announces FDA Approves Less Invasive Surgical Approach for its Heart Pump to Help Patients Avoid Open Heart Surgery
Jan 7, 2020 10:04AM FDA Approves Less Invasive Surgical Approach for Abbott's Heart Pump to Help Patients Avoid Open Heart Surgery
Jan 2, 2020 09:00AM Abbott Hosts Conference Call for Fourth-Quarter Earnings
Dec 13, 2019 10:39AM Abbott Raises Quarterly Dividend 12.5%, Increasing Payouts for 48 Straight Years
Nov 13, 2019 07:46AM Abbott (ABT) Announces Robert B. Ford to Succeed Miles D. White as CEO on March 31
Nov 13, 2019 07:45AM Abbott Announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020
Nov 12, 2019 04:00PM Absolute Reports Fiscal 2020 First Quarter Financial Results
Nov 6, 2019 08:39AM Abbott (ABT) Announces Discovery of New Strain of HIV
Nov 6, 2019 08:37AM Abbott Announces Discovery of New Strain of HIV, Keeping Global Health Community a Step Ahead of the Virus
Nov 6, 2019 08:00AM Klein Independent School District Maximizes One-to-One Program with Absolute Security and Analytics
Oct 21, 2019 09:00AM The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening
Oct 16, 2019 07:30AM Abbott Reports Third-Quarter 2019 Results
View More Recent Stories View Older Stories